SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb sinobiological 40150-D001

$114.00
In stock
SKU
40150-D001
Catalog No.SizePrice (USD)
40150-D001-2020 µL$118.49
40150-D001-5050 µL$222.17
40150-D001-100100 µL$370.28

General Information

Product nameSARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb
Validated applicationsELISA (FAQ Protocol), FCM (FAQ Protocol), ICC/IF (FAQ Protocol), Neutralization
Application notes(Antibody's applications have not been validated with corresponding viruses. Optimal concentrations/dilutions should be determined by the end user.)
SpecificitySARS-CoV-2 Spike RBD Protein (Can block the binding between RBD and ACE2) Has cross-reactivity in ELISA with SARS-CoV-2 Omicron (B.1.1.529) S1+S2 trimer Protein (Cat# 40589-V08H26) SARS-CoV-2 Omicron (B.1.1.529) Spike RBD Protein (Cat# 40592-V08H121) SARS-CoV-2 Delta (B.1.617.2) Spike S1+S2 trimer Protein (Cat# 40589-V08H10) SARS-CoV-2 Delta (B.1.617.2) Spike S1 Protein (Cat# 40591-V08H23) SARS-CoV-2 Spike S1 NTD-Fc & AVI (Cat# 40591-V41H) SARS-CoV-2 Spike S1 Protein (Cat# 40591-V08H) SARS-CoV-2 Spike RBD Protein (Cat# 40592-V08B) SARS-CoV Spike S1 Protein (Cat# 40150-V08B1) Minimal cross-reactivity in ELISA with SARS-CoV-2 Omicron (BA.4.6) Spike S1+S2 trimer Protein (Cat# 40589-V08H37) No cross-reactivity in ELISA with SARS-CoV-2 Omicron (XBB.1.16) Spike S1+S2 trimer Protein (Cat# 40589-V08H48) SARS-CoV-2 Omicron (XBB.1.5) Spike RBD Protein (Cat# 40592-V08H146) SARS-CoV-2 Omicron (XBB.1.5) Spike S1+S2 trimer Protein (Cat# 40589-V08H45) SARS-CoV-2 Omicron (XBB.1) Spike S1+S2 trimer Protein (Cat# 40589-V08H42) SARS-CoV-2 Omicron (XBB) Spike RBD Protein (Cat# 40592-V08H144) SARS-CoV-2 Omicron (BQ.1.1) Spike S1+S2 trimer Protein (Cat# 40589-V08H41) SARS-CoV-2 Omicron (BQ.1.1) Spike RBD Protein (Cat# 40592-V08H143) SARS-CoV-2 Omicron (BF.7) Spike S1+S2 trimer Protein (Cat# 40589-V08H39) SARS-CoV-2 Omicron (BA.4.6/BF.7) Spike RBD Protein (Cat# 40592-V08H140) SARS-CoV-2 Omicron (BA.2.75) Spike RBD Protein (Cat# 40592-V08H135) SARS-CoV-2 Omicron (BA.2.75) Spike S1+S2 trimer Protein (Cat# 40589-V08H36) SARS-CoV-2 Omicron (BA.2.75.2) Spike RBD Protein (Cat# 40592-V08H141) SARS-CoV-2 Omicron (BA.2.75.2) Spike S1+S2 trimer Protein (Cat# 40589-V08H38) SARS-CoV-2 Omicron (BA.2.3.20) Spike RBD Protein (Cat# 40592-V08H142) SARS-CoV-2 Omicron (BA.1.1) Spike S1+S2 trimer Protein (Cat# 40589-V08H29) SARS-CoV-2 Omicron (BA.1.1) Spike RBD Protein (Cat# 40592-V08H129) SARS-CoV-2 Omicron (BA.2) Spike S1+S2 trimer Protein (Cat# 40589-V08H28) SARS-CoV-2 Omicron (BA.2) Spike S1 Protein (Cat# 40591-V08H43) SARS-CoV-2 Omicron (BA.2) Spike RBD Protein (Cat# 40592-V08H123) SARS-CoV-2 Omicron (BA.2) Spike S1-NTD Protein (Cat# 40591-V08H44) SARS-CoV-2 Omicron (BA.2.12.1) Spike RBD Protein (Cat# 40592-V08H132) SARS-CoV-2 Omicron (BA.4/BA.5/BA.5.2) Spike RBD Protein (Cat# 40592-V08H130) SARS-CoV-2 Omicron (BA.5) Spike RBD Protein (Cat# 40592-V08H131) SARS-CoV-2 XD(BA.1 x AY.4) Spike S1+S2 trimer Protein (Cat# 40589-V08H30) SARS-CoV-2 Delta (B.1.617.2) Spike S1 NTD Protein (Cat# 40591-V08H36) SARS-CoV-2 Delta (B.1.617.2) Spike RBD Protein (Cat# 40592-V08H90) MERS-CoV Spike S1 Protein (Cat# 40069-V08B1) HCoV-HKU1 (isolate N1) Spike S1 Protein (Cat# 40021-V08H) HCoV-HKU1 (isolate N5) Spike S1 Protein (Cat# 40602-V08H) HCoV-NL63 Spike S1 Protein (Cat# 40600-V08H) HCoV-229E Spike S1 Protein (Cat# 40601-V08H) HCoV-OC43 Spike S1+S2 ECD Protein (Cat# 40607-V08B)
ImmunogenRecombinant SARS-CoV Spike RBD Protein (Catalog#40150-V08B2)
PreparationIt is a chimeric monoclonal antibody combining the constant domains of the human IgG1 molecule with mouse variable regions. The variable region was obtained from a mouse immunized with purified, recombinant SARS-CoV Spike RBD Protein. The antibody was produced using recombinant antibody technology.
SourceMonoclonal mouse (variable region) / human (kappa / IgG1 constant) chimeric antibody Clone #D001
PurificationProtein A
Formulation50mM Hepes, 100mM NaCl, pH 8.0
ConjugateUnconjugated
FormLiquid
ShippingThis antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
StorageThis antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

Image / Experimental Information

Image 1 DescriptionSerial dilutions of Anti-SARS-CoV-2 Neutralizing Antibody (Catalog# 40150-D001) was detected by SARS-CoV-2 (2019-nCoV) Inhibitor Screening ELISA Kit (Catalog# KIT001). The IC 50 (WT) is typically 0.5-5 nM.
Image 1 Alt TextSARS Coronavirus spike Functional Assay (Agonist Activity) 31918
Image 1 URLSource image
Image 2 DescriptionSerial dilutions of Anti-SARS-CoV-2 Neutralizing Antibody (Catalog# 40150-D001) was detected by SARS-CoV-2 (2019-nCoV) Inhibitor Screening ELISA Kit (Catalog# KIT001). The IC 50 (WT) is typically 0.5-5 nM.
Image 2 Alt TextSARS Coronavirus spike Microneutralizaiton (MN) 31919
Image 2 URLSource image
Image 3 DescriptionSerial dilutions of Anti-SARS-CoV-2 Neutralizing Antibody (Catalog# 40150-D001) was detected by SARS-CoV-2 (2019-nCoV) Inhibitor Screening ELISA Kit (Catalog# KIT001). The IC 50 (WT) is typically 0.5-5 nM.
Image 3 Alt TextSARS Coronavirus spike Flow Cytometry (FC) 32511
Image 3 URLSource image
Image 4 DescriptionSerial dilutions of Anti-SARS-CoV-2 Neutralizing Antibody (Catalog# 40150-D001) was detected by SARS-CoV-2 (2019-nCoV) Inhibitor Screening ELISA Kit (Catalog# KIT001). The IC 50 (WT) is typically 0.5-5 nM.
Image 4 Alt TextSARS Coronavirus spike Immunofluorescence(IF) 32686
Image 4 URLSource image

Background Information

DescriptionThe spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell. Known receptors bind S1 are ACE2 (angiotensin-converting enzyme 2), DPP4 (dipeptidyl peptidase-4), APN (aminopeptidase N), CEACAM (carcinoembryonic antigen-related cell adhesion molecule), Sia (sialic acid), O-ac Sia (O-acetylated sialic acid). The spike is essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. It's been reported that SARS-CoV-2 (COVID-19 coronavirus, 2019-nCoV) can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. The main functions for the Spike protein are summarized as: Mediate receptor binding and membrane fusion; Defines the range of the hosts and specificity of the virus; Main component to bind with the neutralizing antibody; Key target for vaccine design; Can be transmitted between different hosts through gene recombination or mutation of the receptor binding domain (RBD), leading to a higher mortality rate.
References
  1. Shen S, et al . (2007) Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV. Methods Mol Biol. 379: 127-35.
  2. Du L, et al . (2009) The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol. 7 (3): 226-36.
  3. Xiao X, et al . (2004) The SARS-CoV S glycoprotein. Cell Mol Life Sci. 61 (19-20): 2428-30.

[{"title":"Nucleoside-modified RNA for inducing an immune response against SARS-CoV-2","authors":["Norbert Pardi","Drew Weissman"],"journal":"","date":"2026-06-30","pmid":"","doi":""},{"title":"Persistent CD4 + T cell hyporesponsiveness during recovery from prolonged symptomatic SARS-CoV-2 infection.","authors":["Jadith Ziegler","Christina Lawrence","...","Susan Kovats"],"journal":"Cellular Immunology","date":"2026-06-15","pmid":"42320282","doi":"10.1016/j.cellimm.2026.105127"},{"title":"Identification of Prohibitin (PHB) as an Entry Factor of Highly Pathogenic Coronaviruses Using Metabolic Glycoengineering and Photo-Crosslinking Techniques.","authors":["Xingxing Zhu","Xiaoyang Wang","...","Sulong Xiao"],"journal":"Emerging microbes & infections","date":"2026-06-08","pmid":"42253058","doi":""},{"title":"Ribophorin-1 Governs Spike Abundance of Highly Pathogenic Coronaviruses by ER-associated degradation","authors":["Huang Yi-Jiao","Lv Lu","...","Qin Cheng-Feng"],"journal":"bioRxiv","date":"2026-05-21","pmid":"","doi":"10.64898/2026.05.20.726704"},{"title":"LTX-109 as a broad-spectrum antiviral: in vitro and in vivo efficacy against SARS-CoV-2 and Influenza Viruses.","authors":["Matteo Pagliari","Christian Lütken","...","Francesco Bonfante"],"journal":"Antiviral research","date":"2026-05-19","pmid":"42162877","doi":"10.1016/j.antiviral.2026.106444"},{"title":"SARS-CoV-2 infection is associated with hypothalamic orexin suppression and persistent cortical NeuN attenuation","authors":["Gun Young Yoon","Young Cheul Chung","...","Young-Chan Kwon"],"journal":"Journal of neuroinflammation","date":"2026-05-05","pmid":"42087199","doi":"10.1186/s12974-026-03842-y"},{"title":"Discovery of synthetic G-quadruplex DNA as SARS-CoV-2 helicase inhibitor with antiviral, anti-inflammatory and antioxidative properties","authors":["Denisa Bojkova","Katja Steinhorst","...","Stefan Kippenberger"],"journal":"Cell Death Discovery","date":"2026-03-18","pmid":"41851107","doi":"10.1038/s41420-026-03006-0"},{"title":"Onvansertib and vilazodone inhibit SARS-CoV-2 replication via suppression of METTL3 RNA-m 6 A enzymatic activity.","authors":["Ting Zhang","Zi-Ling Wang","...","Yong-Tang Zheng"],"journal":"Antiviral research","date":"2026-02-19","pmid":"41722706","doi":"10.1016/j.antiviral.2026.106376"},{"title":"Disruption of the hypothalamic orexin system links SARS-CoV-2 infection to persistent cortical neuronal pathology","authors":["Yoon Gun Young","Jeong Young-Chul","...","Kwon Young-Chan"],"journal":"bioRxiv","date":"2026-01-23","pmid":"","doi":"10.64898/2026.01.22.701182"},{"title":"Garlic-Derived Phytochemical Candidates Predicted to Disrupt SARS-CoV-2 RBD-ACE2 Binding and Inhibit Viral Entry.","authors":["Martha Susana García-Delgado","Aldo Fernando Herrera-Rodulfo","...","Mauricio Carrillo-Tripp"],"journal":"Molecules (Basel, Switzerland)","date":"2025-12-11","pmid":"41375212","doi":"10.3390/molecules30234616"},{"title":"Split prism-assisted optical aptasensor for ultrasensitive and reliable detection of SARS-CoV-2","authors":[],"journal":"Sensors and Actuators B: Chemical","date":"2025-11-25","pmid":"","doi":"10.1016/j.snb.2025.139185"},{"title":"Engineered migrasomes provide a robust and thermally stable vaccination platform","authors":["Dongju Wang","Haifang Wang","...","Satyajit Rath"],"journal":"eLife","date":"2025-11-13","pmid":"41231123","doi":"10.7554/eLife.97621"},{"title":"Toxicity study of SARS-CoV-2 Spike protein expressed on Bacillus subtilis spores","authors":["Atiqah Hazan","Amalia A. Saperi","...","Sazaly AbuBakar"],"journal":"BMC microbiology","date":"2025-10-06","pmid":"41053546","doi":"10.1186/s12866-025-04186-y"},{"title":"Multivalent Protein Nanorings for Broad and Potent SARS-CoV-2 Neutralization.","authors":["Molood Behbahanipour","Carla Goldin","...","Salvador Ventura"],"journal":"Advanced Healthcare Materials","date":"2025-10-05","pmid":"41047514","doi":"10.1002/adhm.202503487"},{"title":"Development and characterization of a bivalent mRNA vaccine targeting the Delta and Omicron variants of SARS-CoV-2","authors":["Xiao-Chuan Xiong","Na-Na Zhang","...","Qing Ye"],"journal":"Human Vaccines & Immunotherapeutics","date":"2025-09-30","pmid":"41025542","doi":"10.1080/21645515.2025.2562730"},{"title":"Recombinant polypeptides containing at least one immunogenic fragment and uses thereof","authors":["Fritz M. Schomburg","David M. Rancour"],"journal":"","date":"2025-09-09","pmid":"","doi":""},{"title":"Multi-omic spatial profiling reveals the unique SARS-CoV-2 lung microenvironment and collagen VI as a predictive biomarker in severe COVID-19","authors":["Éanna Fennell","Graham S. Taylor","...","Matthew R. Pugh"],"journal":"The European Respiratory Journal","date":"2025-09-01","pmid":"40473310","doi":""},{"title":"Deep generative models design mRNA sequences with enhanced translational capacity and stability","authors":[],"journal":"Science","date":"2025-08-28","pmid":"","doi":"10.1126/science.adr8470"},{"title":"Vaccine for use against coronavirus and variants thereof","authors":["Kakon Nag","Juwel Chandra Baray","...","Naznin Sultana"],"journal":"","date":"2025-08-26","pmid":"","doi":""},{"title":"Direct interaction of HMGB1 with SARS-CoV-2 facilitates its infection via RAGE-dependent endocytosis","authors":["Su Ful Jung","Man Sup Kwak","...","Jeon-Soo Shin"],"journal":"iScience","date":"2025-08-15","pmid":"40740486","doi":"10.1016/j.isci.2025.113063"},{"title":"Exposure to two antigenically distinct SARS-CoV-2 variants broadens neutralization patterns.","authors":["Melanie M Schmitt","Annika Rössler","...","Janine Kimpel"],"journal":"Vaccine","date":"2025-07-04","pmid":"40617091","doi":"10.1016/j.vaccine.2025.127459"},{"title":"Ultrasensitive and long-lasting bioluminescence immunoassay for point-of-care viral antigen detection","authors":["Sungwan Kim","Giwon Cho","...","Hadi Shafiee"],"journal":"Nature Biomedical Engineering","date":"2025-05-30","pmid":"40447759","doi":""},{"title":"Role of N-linked glycosylation sites in human ACE2 in SARS-CoV-2 and hCoV-NL63 infection","authors":["Sabrina Noettger","Fabian Zech","...","Shan-Lu Liu"],"journal":"Journal of virology","date":"2025-05-01","pmid":"40152594","doi":"10.1128/jvi.02202-24"},{"title":"Development of a novel adenovirus type 4 vector as a promising respiratory vaccine vehicle.","authors":["Jinghan Xu","Busen Wang","...","Lihua Hou"],"journal":"Frontiers in Immunology","date":"2025-04-25","pmid":"40276512","doi":""},{"title":"Adding a Twist to Lateral Flow Immunoassays: A Direct Replacement of Antibodies with Helical Affibodies, from Selection to Application.","authors":["Christy J Sadler","Adam Creamer","...","Molly M Stevens"],"journal":"Journal of the American Chemical Society","date":"2025-03-26","pmid":"40135773","doi":""},{"title":"Intranasal Administration of Bivalent RBD Nanoparticles Elicits Strong Systemic Responses That Effectively Block Distal Dissemination of COVID-19.","authors":["Mathurin Seesen","Panya Sunintaboon","...","Tuksin Jearanaiwitayakul"],"journal":"Microbiology and immunology","date":"2025-03-09","pmid":"40059333","doi":"10.1111/1348-0421.13209"},{"title":"Multipartite luciferase peptides and polypeptides","authors":["Virginia Kincaid","Lance P. Encell","...","Trish Hoang"],"journal":"","date":"2025-03-04","pmid":"","doi":""},{"title":"A third COVID-19 vaccine dose in kidney transplant recipients induces antibody response to vaccine and Omicron variants but shows limited Ig subclass switching","authors":["Jenny M. Lee","Jaiprasath Sachithanandham","...","Benjamin M. Liu"],"journal":"Microbiology Spectrum","date":"2025-03-01","pmid":"39887251","doi":""},{"title":"Ultra-high sensitivity optical fiber SARS-CoV-2 biosensor based on triangular gold nanosheets/gold film coupling enhancement","authors":["Bing Xu","Xiaoying Xiang","...","Jianglou Huang"],"journal":"Optical Materials","date":"2025-01-01","pmid":"","doi":"10.1016/j.optmat.2025.116646"},{"title":"Cellular Nanoparticles Treat Coronavirus Infection in Vivo","authors":["Yiyan Yu","Daniela Silva-Ayala","...","Liangfang Zhang"],"journal":"Nano Letters","date":"2024-11-13","pmid":"39535430","doi":"10.1021/acs.nanolett.4c04653"},{"title":"Materials and methods for multidirectional biotransportation in virotherapeutics","authors":["Rajkumar Ganesan","Adam Zwolak","...","Martin Jack Borrok, III"],"journal":"","date":"2024-11-05","pmid":"","doi":""},{"title":"Maternal Preconception COVID-19 Vaccination and Its Protective Effect on Infants after a Breakthrough Infection during Pregnancy","authors":["Yuting Yang","Jie Hu","...","Giuseppe La Torre"],"journal":"Vaccines","date":"2024-10-03","pmid":"","doi":"10.3390/vaccines12101132"},{"title":"Bystander monocytic cells drive infection-independent NLRP3 inflammasome response to SARS-CoV-2","authors":["Leon L. Hsieh","Monika Looney","...","Michael S. Diamond"],"journal":"mBio","date":"2024-10-01","pmid":"39240187","doi":"10.1128/mbio.00810-24"},{"title":"SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like protease","authors":["Wenyan Ren","Weiqi Hong","...","Xiawei Wei"],"journal":"The Journal of Clinical Investigation","date":"2024-09-17","pmid":"","doi":"10.1172/JCI174304"},{"title":"Recreating the biological steps of viral infection on a cell-free bioelectronic platform to profile viral variants of concern","authors":["Zhongmou Chao","Ekaterina Selivanovitch","...","Susan Daniel"],"journal":"Nature Communications","date":"2024-07-03","pmid":"38961055","doi":""},{"title":"Natural evidence of coronaviral 2′-O-methyltransferase activity affecting viral pathogenesis via improved substrate RNA binding","authors":["Jikai Deng","Shimin Yang","...","Yu Chen"],"journal":"Signal transduction and targeted therapy","date":"2024-05-29","pmid":"","doi":"10.1038/s41392-024-01860-x"},{"title":"A Tip Optofluidic Immunoassay System for COVID-19 Immuno-protection Evaluation Using Fingertip Blood","authors":["Li Ruihan","Zhang Binmao","...","Tan Xiaotian"],"journal":"medRxiv","date":"2024-05-01","pmid":"","doi":"10.1101/2024.04.29.24306554"},{"title":"An optimized high-throughput SARS-CoV-2 dual reporter trans-complementation system for antiviral screening in vitro and in vivo","authors":["Yingjian Li","Xue Tan","...","Yu Chen"],"journal":"Virologica Sinica","date":"2024-03-26","pmid":"38548102","doi":"10.1016/j.virs.2024.03.009"},{"title":"Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial","authors":["Han-Sol Park","Anna Yin","...","David J. Sullivan"],"journal":"JCI insight","date":"2024-03-14","pmid":"38483534","doi":"10.1172/jci.insight.178460"},{"title":"Ciclopirox inhibits SARS-CoV-2 replication by promoting the degradation of the nucleocapsid protein","authors":["Xiafei Wei","Yuzheng Zhou","...","Zheng Zhang"],"journal":"Acta Pharmaceutica Sinica. B","date":"2024-03-12","pmid":"","doi":"10.1016/j.apsb.2024.03.009"},{"title":"Digital Surface-Enhanced Raman Spectroscopy–Lateral Flow Test Dipstick: Ultrasensitive, Rapid Virus Quantification in Environmental Dust","authors":["Wei Wang","Sonali Srivastava","...","Peter J. Vikesland"],"journal":"Environmental Science & Technology","date":"2024-03-07","pmid":"38452107","doi":""},{"title":"Reduced control of SARS-CoV-2 infection associates with lower mucosal antibody responses in pregnancy","authors":["Laura A. St Clair","Raghda E. Eldesouki","...","Michael J. Imperiale"],"journal":"mSphere","date":"2024-03-01","pmid":"38426787","doi":"10.1128/msphere.00812-23"},{"title":"SARS-CoV-2 3CLpro Main Protease Drives Cytoskeletal Reorganization and Tunnelling Nanotube Formation for Stealth Intercellular Infection","authors":["Christopher Overall","Georgina Butler","...","Eric Jan"],"journal":"Europe PMC","date":"2024-02-21","pmid":"","doi":"10.21203/rs.3.rs-3918469"},{"title":"SARS-CoV-2-Mimicking Pseudoviral Particles Accelerate α-Synuclein Aggregation In Vitro.","authors":["Gianluca Zilio","Anna Masato","...","Luigi Bubacco"],"journal":"ACS Chemical Neuroscience","date":"2024-01-18","pmid":"38131609","doi":"10.1021/acschemneuro.3c00468"},{"title":"Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models","authors":["Lays Cordeiro Guimaraes","Pedro Augusto Carvalho Costa","...","Pedro Pires Goulart Guimaraes"],"journal":"Nature Communications","date":"2024-01-18","pmid":"38238326","doi":"10.1038/s41467-024-44830-1"},{"title":"A cardiotoxicity-eliminated ACE2 variant as a pan-inhibitor against coronavirus cell invasion.","authors":["Han Feng","Linpu Yang","...","Tao Xu"],"journal":"Molecular therapy : the journal of the American Society of Gene Therapy","date":"2024-01-08","pmid":"37974399","doi":"10.1016/j.ymthe.2023.11.019"},{"title":"Wearable MXene‐Graphene Sensing of Influenza and SARS‐CoV‐2 Virus in Air and Breath: From Lab to Clinic","authors":[],"journal":"Advanced Materials Technologies","date":"2023-12-27","pmid":"","doi":"10.1002/admt.202201787"},{"title":"A bivalent form of a RBD-specific synthetic antibody effectively neutralizes SARS-CoV-2 variants.","authors":["Dong-Gun Kim","Uijin Kim","...","Hak-Sung Kim"],"journal":"Antiviral research","date":"2023-12-16","pmid":"37944822","doi":"10.1016/j.antiviral.2023.105738"},{"title":"Antibody cocktail against SARS-CoV-2 spike protein","authors":["Matthew K. Robinson","Pavel Nikitin","...","John P. Dowling"],"journal":"","date":"2023-12-05","pmid":"","doi":""},{"title":"Naked-Eye Readable Microarray for Rapid Profiling of Antibodies against Multiple SARS-CoV-2 Variants","authors":["Jingjie Nan","Yuan Chen","...","Bai Yang"],"journal":"Nano Letters","date":"2023-12-04","pmid":"38047611","doi":"10.1021/acs.nanolett.3c03139"},{"title":"Additive manufacturing of carbon black immunosensors based on covalent immobilization for portable electrochemical detection of SARS-CoV-2 spike S1 protein","authors":["Luiz Ricardo Guterres Silva","Jéssica Santos Stefano","...","Bruno Campos Janegitz"],"journal":"Talanta Open","date":"2023-12-01","pmid":"","doi":"10.1016/j.talo.2023.100250"},{"title":"Study of the Immunogenicity of Combination of Recombinant RBD (Omicron) and Nucleocapsid Proteins of SARS-CoV-2 Expressed in Pichia Pastoris","authors":["Shakhnoz Azimova","Sobirdjan Sasmakov","...","Aygul Yarilkaganova"],"journal":"The Open Biochemistry Journal","date":"2023-11-30","pmid":"","doi":"10.2174/011874091x273716231122102205"},{"title":"Three doses of COVID-19 mRNA vaccine induce class-switched antibody responses in inflammatory arthritis patients on immunomodulatory therapies","authors":["Jenny M. Lee","Alexis Figueroa","...","Justin R. Bailey"],"journal":"Frontiers in Immunology","date":"2023-10-24","pmid":"38022602","doi":"10.3389/fimmu.2023.1266370"},{"title":"SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations","authors":["Andrew P. Hederman","Harini Natarajan","...","Margaret E. Ackerman"],"journal":"Nature Communications","date":"2023-08-24","pmid":"37620337","doi":"10.1038/s41467-023-40960-0"},{"title":"Characterization of stability, safety and immunogenicity of the mRNA lipid nanoparticle vaccine Iribovax® against COVID-19 in nonhuman primates.","authors":["Parvin Zamani","Mohammad Mashreghi","...","Sina Mozaffari-Jovin"],"journal":"Journal of controlled release : official journal of the Controlled Release Society","date":"2023-08-21","pmid":"37355212","doi":"10.1016/j.jconrel.2023.06.025"},{"title":"Large language models generate functional protein sequences across diverse families.","authors":["Ali Madani","Ben Krause","...","Nikhil Naik"],"journal":"Nature Biotechnology","date":"2023-08-14","pmid":"36702895","doi":"10.1038/s41587-022-01618-2"},{"title":"Strong immunogenicity & protection in mice with PlaCCine: A COVID-19 DNA vaccine formulated with a functional polymer","authors":["Sood Subeena","Matar Majed M.","...","Anwer Khursheed"],"journal":"bioRxiv","date":"2023-08-02","pmid":"","doi":"10.1101/2023.08.01.551509"},{"title":"Multifunctional Nanoprobe-Amplified Enzyme-Linked Immunosorbent Assay on Capillary: A Universal Platform for Simple, Rapid, and Ultrasensitive Dual-Mode Pathogen Detection.","authors":["Chunpeng Jiao","Wei Duan","...","Chaoyong Yang"],"journal":"Analytical Chemistry","date":"2023-08-02","pmid":"37402321","doi":"10.1021/acs.analchem.3c01375"},{"title":"An inhaled bioadhesive hydrogel to shield non-human primates from SARS-CoV-2 infection","authors":["Xuan Mei","Junlang Li","...","Ke Cheng"],"journal":"Nature Materials","date":"2023-07-01","pmid":"36759564","doi":"10.1038/s41563-023-01475-7"},{"title":"Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization","authors":["Scott A. McConnell","Jaiprasath Sachithanandham","...","Arturo Casadevall"],"journal":"Cell chemical biology","date":"2023-06-23","pmid":"","doi":"10.1016/j.chembiol.2023.05.011"},{"title":"SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice.","authors":["Eun Kim","Muhammad S Khan","...","Andrea Gambotto"],"journal":"Microbiology Spectrum","date":"2023-06-19","pmid":"37162333","doi":""},{"title":"SARS-CoV-2 Infection Induces HMGB1 Secretion Through Post-Translational Modification and PANoptosis","authors":["Man Sup Kwak","Seoyeon Choi","...","Jeon-Soo Shin"],"journal":"Immune Network","date":"2023-06-01","pmid":"","doi":"10.4110/in.2023.23.e26"},{"title":"Interferon-dependent signaling is critical for viral clearance in airway neutrophils","authors":["Camilla Margaroli","Timothy Fram","...","Amit Gaggar"],"journal":"JCI insight","date":"2023-05-22","pmid":"37071484","doi":"10.1172/jci.insight.167042"},{"title":"Longitudinal analyses using 18 F-Fluorodeoxyglucose positron emission tomography with computed tomography as a measure of COVID-19 severity in the aged, young, and humanized ACE2 SARS-CoV-2 hamster models.","authors":["Yu Cong","Ji Hyun Lee","...","Reed F Johnson"],"journal":"Antiviral research","date":"2023-05-15","pmid":"37068595","doi":"10.1016/j.antiviral.2023.105605"},{"title":"Algorithm for Optimized mRNA Design Improves Stability and Immunogenicity.","authors":["He Zhang","Liang Zhang","...","Liang Huang"],"journal":"Nature","date":"2023-05-02","pmid":"37130545","doi":"10.1038/s41586-023-06127-z"},{"title":"Antibody Correlates of Protection for COVID-19 Convalescent Plasma Associated with Reduced Outpatient Hospitalizations","authors":["Park Han-Sol","Barranta Caelan","...","Sullivan David J."],"journal":"medRxiv","date":"2023-04-24","pmid":"","doi":""},{"title":"A handheld plug-and-play microfluidic liquid handling automation platform for immunoassays","authors":["Sheng Wang","Baichen Li","...","Zhenyu Li"],"journal":"HardwareX","date":"2023-04-17","pmid":"","doi":"10.1016/j.ohx.2023.e00420"},{"title":"Development, Validation, and Utilization of a Luminex-Based SARS-CoV-2 Multiplex Serology Assay","authors":["Daisy R. Roy","Troy J. Kemp","...","Ligia A. Pinto"],"journal":"Microbiology Spectrum","date":"2023-04-13","pmid":"","doi":"10.1128/spectrum.03898-22"},{"title":"Suramin binds and inhibits infection of SARS-CoV-2 through both spike protein-heparan sulfate and ACE2 receptor interactions","authors":["Paul S. Kwon","Shirley Xu","...","Jonathan S. Dordick"],"journal":"Communications Biology","date":"2023-04-08","pmid":"37031303","doi":"10.1038/s42003-023-04789-z"},{"title":"Neonatal SHIV infection in rhesus macaques elicited heterologous HIV-1-neutralizing antibodies.","authors":["Bhavna Hora","Hui Li","...","Wilton B Williams"],"journal":"Cell Reports","date":"2023-04-03","pmid":"36924501","doi":""},{"title":"COVID-19 Diagnosis and SARS-CoV-2 Strain Identification by a Rapid, Multiplexed, Point-of-Care Antibody Microarray","authors":["Jacob T. Heggestad","Rhett J. Britton","...","Ashutosh Chilkoti"],"journal":"Analytical Chemistry","date":"2023-03-24","pmid":"36961989","doi":"10.1021/acs.analchem.2c05180"},{"title":"Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice","authors":["Dennis Horvath","Nigel Temperton","...","Jan ter Meulen"],"journal":"Scientific Reports","date":"2023-03-21","pmid":"","doi":""},{"title":"Reduced control of SARS-CoV-2 infection is associated with lower mucosal antibody responses in pregnant women","authors":["Clair Laura A. St","Eldesouki Raghda E.","...","Klein Sabra L."],"journal":"medRxiv","date":"2023-03-20","pmid":"","doi":""},{"title":"Immunogenicity of COVID-eVax Delivered by Electroporation Is Moderately Impacted by Temperature and Molecular Isoforms.","authors":["Federico D'Alessio","Lucia Lione","...","Fabio Palombo"],"journal":"Vaccines","date":"2023-03-16","pmid":"36992261","doi":""},{"title":"The SpACE-CCM: A facile and versatile cell culture medium-based biosensor for detection of SARS-CoV-2 spike-ACE2 interaction.","authors":["Youngwook Ham","Nam-Chul Cho","...","Sungchan Cho"],"journal":"Biosensors & bioelectronics","date":"2023-03-14","pmid":"36827795","doi":"10.1016/j.bios.2023.115169"},{"title":"OligoBinders: Bioengineered Soluble Amyloid-like Nanoparticles to Bind and Neutralize SARS-CoV-2.","authors":["Molood Behbahanipour","Roger Benoit","...","Salvador Ventura"],"journal":"ACS Applied Materials & Interfaces","date":"2023-03-10","pmid":"36890692","doi":""},{"title":"An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animals.","authors":["Anna Offersgaard","Carlos Rene Duarte Hernandez","...","Judith Margarete Gottwein"],"journal":"iScience","date":"2023-02-17","pmid":"36644321","doi":"10.1016/j.isci.2023.105949"},{"title":"Profiling humoral immunity after mixing and matching COVID-19 vaccines using SARS-CoV-2 variant protein microarrays","authors":["Ho-Chang Kuo","Kuang-Che Kuo","...","Guan-Da Syu"],"journal":"Molecular & cellular proteomics : MCP","date":"2023-02-12","pmid":"","doi":"10.1016/j.mcpro.2023.100507"},{"title":"Long-term and effective neutralization against omicron sublineages elicited by four platform COVID-19 vaccines as a booster dose","authors":["Yuemiao Zhang","Meng-Ting Luo","...","Lihong Zhang"],"journal":"Cell discovery","date":"2023-02-08","pmid":"36754955","doi":"10.1038/s41421-023-00518-2"},{"title":"Flexible Label-Free Platinum and Bio-PET-Based Immunosensor for the Detection of SARS-CoV-2","authors":["Rodrigo Vieira Blasques","Paulo Roberto de Oliveira","...","Bruno Campos Janegitz"],"journal":"Biosensors","date":"2023-01-26","pmid":"","doi":""},{"title":"mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19","authors":["Christina M. Kackos","Sherri L. Surman","...","Heba H. Mostafa"],"journal":"Microbiology Spectrum","date":"2023-01-25","pmid":"36695597","doi":"10.1128/spectrum.04240-22"},{"title":"A Novel High Sensitivity Optical Fiber Lspr Sars-Cov-2 Sensor Based on Triangular Gold Nanosheets","authors":["Bing Xu","Xiaoying Xiang","...","Decheng Wang"],"journal":"Europe PMC","date":"2023-01-19","pmid":"","doi":"10.2139/ssrn.4327579"},{"title":"Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients","authors":["Santosh Dhakal","Tong Yu","...","Sabra L Klein"],"journal":"Open Forum Infectious Diseases","date":"2023-01-01","pmid":"","doi":"10.1093/ofid/ofac677"},{"title":"An Investigation into the Role of Protein-Based Viral Structural Features in Mediating the Infectivity of SARS-CoV-2","authors":["Bains, Arjan Singh "],"journal":"","date":"2023-01-01","pmid":"","doi":""},{"title":"Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2","authors":["Annarita Miluzio","Alessandro Cuomo","...","Stefano Biffo"],"journal":"EBioMedicine","date":"2022-12-28","pmid":"36584595","doi":""},{"title":"Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: A population-based study in Hong Kong","authors":["Runhong Zhou","Na Liu","...","Zhiwei Chen"],"journal":"The Lancet Regional Health: Western Pacific","date":"2022-12-23","pmid":"","doi":"10.1016/j.lanwpc.2022.100660"},{"title":"Control of SARS-CoV-2 infection by MT1-MMP-mediated shedding of ACE2","authors":["Xuanming Guo","Jianli Cao","...","Hoi Leong Xavier Wong"],"journal":"Nature Communications","date":"2022-12-23","pmid":"36564389","doi":"10.1038/s41467-022-35590-x"},{"title":"Bulk IgG glycosylation predicts COVID-19 severity and vaccine antibody response.","authors":["Michelle K Ash","Pavan P Bhimalli","...","Jeffrey R Schneider"],"journal":"Cell Reports","date":"2022-12-16","pmid":"36493786","doi":"10.1016/j.celrep.2022.111799"},{"title":"Critical Offset Magnetic PArticle SpectroScopy for rapid and highly sensitive medical point-of-care diagnostics","authors":["Patrick Vogel","Martin Andreas Rückert","...","Volker Christian Behr"],"journal":"Nature Communications","date":"2022-11-24","pmid":"","doi":"10.1038/s41467-022-34941-y"},{"title":"Transplacental transmission of SARS‐CoV‐2 immunoglobulin G antibody to infants from maternal COVID‐19 vaccine immunization before pregnancy","authors":["Yuting Yang","Huiwu Xing","Yao Zhao"],"journal":"Journal of medical virology","date":"2022-11-18","pmid":"36367230","doi":"10.1002/jmv.28296"},{"title":"Development of a rapid, simple, and sensitive point-of-care technology platform utilizing ternary NanoLuc","authors":["Emily A. Torio","Valerie T. Ressler","...","Melanie L. Dart"],"journal":"Frontiers in Microbiology","date":"2022-10-26","pmid":"36386626","doi":""},{"title":"Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins","authors":["Kyle L. O’Donnell","Tylisha Gourdine","...","Andrea Marzi"],"journal":"Frontiers in Immunology","date":"2022-10-24","pmid":"","doi":"10.3389/fimmu.2022.1025500"},{"title":"Development and characterisation of cysteine-based gold electrodes for the electrochemical biosensing of the SARS-CoV-2 spike antigen.","authors":["Nursel Olgaç","Yücel Şahin","Lokman Liv"],"journal":"The Analyst","date":"2022-10-12","pmid":"36052711","doi":"10.1039/d2an01225a"},{"title":"Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases","authors":["Hu Li","Yuting Wang","...","Hong Ren"],"journal":"Frontiers in Immunology","date":"2022-10-05","pmid":"","doi":"10.3389/fimmu.2022.988004"},{"title":"Isolation of a human SARS-CoV-2 neutralizing antibody from a synthetic phage library and its conversion to fluorescent biosensors","authors":["Haimei Li","Bo Zhu","...","Hiroshi Ueda"],"journal":"Scientific Reports","date":"2022-09-15","pmid":"36109569","doi":"10.1038/s41598-022-19699-z"},{"title":"SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN ® , induces robust humoral and cellular immunity in mice and non-human primates","authors":["Reza Alimohammadi","Meysam Porgoo","...","Vahid Khoddami"],"journal":"NPJ vaccines","date":"2022-09-02","pmid":"36056015","doi":"10.1038/s41541-022-00528-3"},{"title":"Folic acid restricts SARS-CoV-2 invasion by methylating ACE2","authors":["Yuanzhou Zhang","Yechun Pang","...","Xiaoying Luo"],"journal":"Frontiers in Microbiology","date":"2022-08-17","pmid":"36060767","doi":"10.3389/fmicb.2022.980903"},{"title":"SARS-CoV-2 pseudotyped virus persists on the surface of multiple produce but can be inactivated with gaseous ozone","authors":["Mehrad Mortazavi","Arjan Bains","...","Patricia J. LiWang"],"journal":"Heliyon","date":"2022-08-15","pmid":"","doi":"10.1016/j.heliyon.2022.e10280"},{"title":"Evaluation of Immune Evasion in SARS-CoV-2 Delta and Omicron variants","authors":["Armi M. Chaudhari","Madhvi Joshi","...","Chaitanya Joshi"],"journal":"Computational and Structural Biotechnology Journal","date":"2022-08-08","pmid":"","doi":"10.1016/j.csbj.2022.08.010"},{"title":"Rational development of a combined mRNA vaccine against COVID-19 and influenza","authors":["Qing Ye","Mei Wu","...","Cheng-Feng Qin"],"journal":"NPJ vaccines","date":"2022-07-26","pmid":"35882870","doi":"10.1038/s41541-022-00478-w"}]

Reviews

Write Your Own Review
You're reviewing:SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb sinobiological 40150-D001
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.